The following table presents the benefits recognized from AMPTC in the three and nine months ended September 30, 2026 and 2025.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
September 30, | | Nine Months Ended
September 30, | | | | | 2026 | | 2025 | | 2026 | | 2025 | | | | | | | | | | | | | | | | (In thousands) | | | Transactions recorded to cost of revenues: | | | | | | | | | | | | AMPTC generated | $ | 64,215 | | | $ | 67,627 | | | $ | 195,160 | | | $ | 182,298 | | | | | Discount from sale of AMPTC generated during 2025 (1) | — | | | — | | | (18,905) | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | Adjustments to record AMPTC generated in period at fair value | (5,600) | | | — | | | (17,031) | | | — | | | | | | Net benefit from AMPTC reducing cost of revenues | $ | 58,615 | | | $ | 67,627 | | | $ | 159,224 | | | $ | 182,298 | | | | | | | | | | | | | | | |
|